Miss. Murugathas Viveka

Abstracts

Presented at International Forum

1. Vijayakumar, G., Murugathas, V., Balendrarajah, K., Arasaratnam, V. and Muhunthan, K. (2024). Influence of Body Mass Index of the distribution of dyslipidaemia in women affected with Polycystic Ovary Syndrome. Beyond the Blueprint of Life. Fourth International Conference on Frontiers in Molecular Life Sciences. Institute of Biochemistry, Molecular Biology and Biotechnology, University of Colombo. 26^th to 27^th September, 2024. 57.

2. Balendrarajah, K., Vijayakumar, G., Murugathas, V., Arasaratnam, V. and Muhunthan, K. (2024). Abilities of Triglyceride-Glucose –Body Mass Index and Triglyceride – Glucose-Index to identify dyslipidaemia among the women with Polycystic Ovary Syndrome Attending Teaching Hospital, Jaffna, Sri Lanka. Unravelling the paradigm shift: Revolutions in the Era of AI. Abstracts of the 17^th International Research Conference (KDUiRC). 26^th to 27^th September, 2024. 23.

3. Viveka, M., Kajanthini, B., Gowthame, V., Sutharsan, M., Muhunthan, K. and Arasaratnam, V. (2024). Prevalence of dyslipidaemia in women with polycystic ovarian syndrome attending Teaching Hospital, Jaffna. Developing a future Multidisciplinary Workforce in Rapidly Changing Health Care.’ Proceedings of the 2^nd International Research Symposium of the Faculty of Allie Health Sciences, University of Ruhuna, Galle Sri Lanka. July, 2024. 127.

4. Vijayakumar, G., Murugathas, V., Balendrarajah, K., Arasaratnam, V., Muhunthan, K. and Aranraj, T. (2024). Anthropometric indices effect on diabetes & pre-diabetes of polycystic ovarian syndrome women treated at Teaching Hospital, Jaffna. One Health for Sustainable & Healthy Living of Human Animals & Ecosystem. 2^nd International Research Symposium on Traditional Medicine, Faculty of Graduate Studies, University of Kelaniya, Sri Lanka. 3^rd – 5^th May 2024, pp. 14.

5. Viveka, M., Kajanthini, B., Gowthame, V., Arasaratnam, V., Muhunthan, K. and Sutharsan, M. (2024). Evaluation of anthropometric patterns in women with polycystic ovarian syndrome; at Teaching Hospital, Jaffna. Exploring Trends in Digital Health for Health Care Innovations with Sustainability Health Equity. International Research conference in Health Sciences 2024 (IRCHS 2024), Faculty of Allied Health Sciences, University of Sri Jayewardenepura, Sri Lanka.2^nd of April 2024, pp. 84.

Presented at National Forum               

1. Balendrarajah, K., Vijayakumar, G., Murugathas, V., Muhunthan, K., Thayaananthan, K. and Arasaratnam, V. (2024). Evaluation of lipid profiles of women with polycystic ovarian syndrome at Teaching Hospital, Jaffna. Navigating Challenges: Quality at the Forefront. 9^th Annual Academic Sessions-2024, College of Chemical Pathologists of Sri Lanka. 12^th and – 13^th July, 2024, pp. 93.

2. Balendrarajah, K., Vijayakumar, G., Murugathas, V., Arasaratnam, V. and Muhunthan, K. (2024). Correlation between triglyceride glucose index and lipid profiles of women with POCS attending Teaching Hospital, Sri Lanka Journal of Diabetes Endocrinology and Metabolism. August, 2024. 15(2):

3. Vijayakumar, G., Balendrarajah, K., Murugathas, V., Arasaratnam, V. and Muhunthan, K. (2024). Cardiovascular risk assessment in obese PCOS women based on LDL/HDL ratio. Quality Health Care through Standards in Training & Service Delivery – A Right of All Women. Proceedings of the 57^th Annual Academic Congress 2024. 30^th August to 1^st September 2024. The Sri Lanka College of Obstetrician and Gynaecologists, The Sri Lanka Journal of Obstetrician and Gynaecologists (SLJOG-Supplement Issue). 133.

4. Murugathas, V., Vijayakumar, G., Balendrarajah, K., Arasaratnam, V. and Muhunthan, K. (2024). Do metabolic risks of PCOS differ based on the health seeking care facilities of the general Gynaecology Vs. Subfertility? Abstracts of the 57^th Anniversary Annual Academic Sessions of the Ceylon College of Physicians in Collaboration with the Royal College of Physicians and Royal College of Physicians of Edinburgh. 19^th to 21^st September, 2024. The Journal of the Ceylon College of Physicians. 55(11 Supplement): 35.

• Molecular Biology and Biotechnology.
• CVD – Atrial Fibrillation